MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 206 filers reported holding MEDICINES CO in Q3 2016. The put-call ratio across all filers is 0.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $5,028,000 | +71.5% | 59,191 | +0.9% | 0.01% | +55.6% |
| Q3 2019 | $2,932,000 | +47.3% | 58,634 | +7.4% | 0.01% | +50.0% |
| Q2 2019 | $1,990,000 | +41.6% | 54,570 | +8.6% | 0.01% | +50.0% |
| Q1 2019 | $1,405,000 | +58.2% | 50,267 | +8.4% | 0.00% | +33.3% |
| Q4 2018 | $888,000 | -34.6% | 46,387 | +2.2% | 0.00% | -25.0% |
| Q3 2018 | $1,357,000 | -16.8% | 45,367 | +2.1% | 0.00% | -20.0% |
| Q2 2018 | $1,631,000 | +14.1% | 44,437 | +2.4% | 0.01% | 0.0% |
| Q1 2018 | $1,430,000 | +32.4% | 43,410 | +9.9% | 0.01% | +25.0% |
| Q4 2017 | $1,080,000 | -24.7% | 39,499 | +2.0% | 0.00% | -20.0% |
| Q3 2017 | $1,434,000 | -13.5% | 38,720 | -11.2% | 0.01% | -28.6% |
| Q2 2017 | $1,658,000 | -11.1% | 43,610 | +14.4% | 0.01% | -12.5% |
| Q1 2017 | $1,864,000 | +45.3% | 38,120 | +0.8% | 0.01% | +33.3% |
| Q4 2016 | $1,283,000 | -4.7% | 37,800 | +6.0% | 0.01% | 0.0% |
| Q3 2016 | $1,346,000 | +17.1% | 35,670 | +4.4% | 0.01% | +20.0% |
| Q2 2016 | $1,149,000 | +12.8% | 34,180 | +6.6% | 0.01% | 0.0% |
| Q1 2016 | $1,019,000 | -8.3% | 32,060 | +7.8% | 0.01% | 0.0% |
| Q4 2015 | $1,111,000 | +4.5% | 29,750 | +6.2% | 0.01% | -16.7% |
| Q3 2015 | $1,063,000 | +44.6% | 28,000 | +8.9% | 0.01% | +50.0% |
| Q2 2015 | $735,000 | +7.9% | 25,700 | +5.8% | 0.00% | 0.0% |
| Q1 2015 | $681,000 | +3.3% | 24,300 | +2.1% | 0.00% | 0.0% |
| Q4 2014 | $659,000 | -81.5% | 23,800 | -85.1% | 0.00% | -80.0% |
| Q3 2014 | $3,561,000 | -36.6% | 159,550 | -17.5% | 0.02% | -37.5% |
| Q2 2014 | $5,619,000 | +739.9% | 193,350 | +721.0% | 0.03% | +700.0% |
| Q1 2014 | $669,000 | -25.7% | 23,550 | +1.1% | 0.00% | -20.0% |
| Q4 2013 | $900,000 | -68.7% | 23,300 | -72.9% | 0.01% | -72.2% |
| Q3 2013 | $2,879,000 | -83.9% | 85,900 | -85.2% | 0.02% | -84.5% |
| Q2 2013 | $17,863,000 | – | 580,700 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
| SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
| Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
| Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
| RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
| DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
| Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
| WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
| Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
| Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |